483sOnline Subscribe

Search By Date Issued

Search By Category

Drug
Device
Clinical

Search By Company/

Clinical Investigator

Search By Region

Search By FDA Investigator

Search By Keyword

Log in to start searching through our library of thousands of 483s, or Subscribe Now to 483sOnline.com to uncover exactly what FDA Inspectors are thinking about. It’s your own personal pre-investigation intelligence tool that identifies exactly what investigators are focusing on so you can be prepared – before they show up.

Cytovance Biologics, Inc. - May 19, 2019

Issue Date

May 19, 2019

Region

Southwest

Category

Drug
$117.00

Cytovance Biologics, Inc.

Contact Name

Jesse D. McCool

Contact Title

Sr. Vice President

Form483 Address 1

800 Research Pkwy.

Form483 Address 2

Ste. 200

Form483 City

Oklahoma

Form483 State

OK

Form483 Postal

73104

Form483 Country

United States

Inspection Range

May 01, 2019 - May 09, 2019

Pages

2

First Observation

Failure to thoroughly review and/or conduct adequate investigations into any unexplained discrepancy or failure.
Investigator(s): Margaret M. Annes